CVS Health Corp
CVS: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| hdS | LOCK|ZD | LOCK|@>$xZJ> |
CVS Health Earnings: 2026 Guidance Maintained After Strong Trends in Late 2025
In the fourth quarter, CVS turned in 8% sales growth and 8% adjusted EPS decline, or slightly higher than consensus. The firm largely confirmed targets given at its December investor day, too, albeit trimming its operating cash flow outlook to $9 billion from $10 billion after a big beat in 2025.
